{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:00:05Z","timestamp":1790078405159,"version":"4.0.1"},"reference-count":44,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD052102, HD052104"],"award-info":[{"award-number":["HD052102, HD052104"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006084","name":"Office of AIDS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00199","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T18:40:21Z","timestamp":1464028821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs"],"prefix":"10.3389","volume":"7","author":[{"given":"Russell B.","family":"Van Dyke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Gould","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Seage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"B1","author":"CDC","year":"2016","journal-title":"Enhanced Perinatal Surveillance \u2013 15 Areas, 2005-2008"},{"issue":"13","key":"B2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/01.aids.0000242814.42344.77","article-title":"Mitochondrial dysfunction following perinatal exposure to nucleoside analogues","volume":"20","author":"Blanche","year":"2006","journal-title":"AIDS"},{"issue":"5\u20136","key":"B3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.mito.2004.07.025","article-title":"Mitochondrial dysfunction in AIDS and its treatment","volume":"4","author":"Gerschenson","year":"2004","journal-title":"Mitochondrion"},{"issue":"9184","key":"B4","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"issue":"3","key":"B5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00126334-200011010-00009","article-title":"Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts","volume":"25","author":"The Perinatal Safety Review Working Group","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"B6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/01.qai.0000194735.66322.d9","article-title":"In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts","volume":"41","author":"Brogly","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"B7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/QAD.0000000000000916","article-title":"Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design","volume":"30","author":"Williams","year":"2016","journal-title":"AIDS"},{"issue":"7","key":"B8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/apc.2011.0068","article-title":"In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States","volume":"25","author":"Griner","year":"2011","journal-title":"AIDS Patient Care STDS"},{"issue":"9","key":"B9","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/aje\/kwr401","article-title":"A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers","volume":"175","author":"Williams","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"10","key":"B10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/cid\/cir131","article-title":"Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy","volume":"52","author":"Gandhi","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"B11","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/ac303188j","article-title":"Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium","volume":"85","author":"Himes","year":"2013","journal-title":"Anal Chem"},{"issue":"17","key":"B12","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1097\/00002030-200411190-00019","article-title":"Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe","volume":"18","author":"Thorne","year":"2004","journal-title":"AIDS"},{"issue":"1","key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1468-1293.2008.00520.x","article-title":"Increased rate of prematurity associated with antenatal antiretroviral therapy in a German\/Austrian cohort of HIV-1-infected women","volume":"9","author":"Grosch-Woerner","year":"2008","journal-title":"HIV Med"},{"issue":"4","key":"B14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy","volume":"204","author":"Powis","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"B15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/infdis\/jis728","article-title":"Combination antiretroviral use and preterm birth","volume":"207","author":"Watts","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jamapediatrics.2014.1889","article-title":"Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants","volume":"169","author":"Williams","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"3","key":"B17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/QAI.0b013e31802e2229","article-title":"Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study","volume":"44","author":"Watts","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"B18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/INF.0b013e318234c886","article-title":"Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications","volume":"30","author":"Crain","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"B19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/QAI.0b013e318221c56a","article-title":"Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children","volume":"57","author":"Heidari","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"B20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jpeds.2012.12.034","article-title":"Growth and body composition of uninfected children exposed to human immunodeficiency virus: comparison with a contemporary cohort and United States National Standards","volume":"163","author":"Neri","year":"2013","journal-title":"J Pediatr"},{"issue":"8","key":"B21","first-page":"685","article-title":"Weight, height and human immunodeficiency virus infection in young children of infected mothers","volume":"14","author":"The European Collaborative Study","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"B22","article-title":"Patterns of childhood growth in HIV-exposed uninfected (HEU) children in the Pediatric HIV\/AIDS Cohort Study (PHACS)","author":"Jacobson","year":"2013"},{"issue":"12","key":"B23","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/infdis\/jir188","article-title":"Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202","volume":"203","author":"McComsey","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"B24","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jpeds.2007.12.020","article-title":"Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus","volume":"152","author":"Purdy","year":"2008","journal-title":"J Pediatr"},{"issue":"5","key":"B25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1128\/AAC.48.6.2346.2004","article-title":"Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques","volume":"48","author":"Van Rompay","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"B26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00042560-200203010-00001","article-title":"Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta)","volume":"29","author":"Tarantal","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"B27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/cid\/civ437","article-title":"Lower newborn bone mineral content associated with maternal use of tenofovir disoproxil fumarate during pregnancy","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"B28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/jbmr.2138","article-title":"Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study","volume":"29","author":"Zhu","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"9","key":"B29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/QAD.0b013e328352d135","article-title":"Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants","volume":"26","author":"Siberry","year":"2012","journal-title":"AIDS"},{"issue":"1","key":"B30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2010.08.620","article-title":"Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study)","volume":"57","author":"Lipshultz","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"B31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/QAD.0000000000000499","article-title":"Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers","volume":"29","author":"Lipshultz","year":"2015","journal-title":"AIDS"},{"issue":"7","key":"B32","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/QAD.0b013e32835cf21c","article-title":"Cardiac biomarkers in HIV-exposed uninfected children","volume":"27","author":"Wilkinson","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"B33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/toxsci\/kfq235","article-title":"Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs)","volume":"118","author":"Divi","year":"2010","journal-title":"Toxicol Sci"},{"issue":"2","key":"B34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00126334-200306010-00010","article-title":"Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers","volume":"33","author":"Poirier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"B35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.taap.2003.11.034","article-title":"Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs","volume":"199","author":"Poirier","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"B36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","article-title":"Antiretroviral neurotoxicity","volume":"18","author":"Robertson","year":"2012","journal-title":"J Neurovirol"},{"issue":"2","key":"B37","doi-asserted-by":"publisher","first-page":"e55753","DOI":"10.1371\/journal.pone.0055753","article-title":"Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine","volume":"8","author":"Zuena","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"B38","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1097\/INF.0000000000000314","article-title":"Discordance of cognitive and academic achievement outcomes in youth with perinatal HIV exposure","volume":"33","author":"Garvie","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"B39","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/09540121.2011.575120","article-title":"Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure","volume":"23","author":"Malee","year":"2011","journal-title":"AIDS Care"},{"issue":"2","key":"B40","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1542\/peds.2009-1112","article-title":"Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants","volume":"125","author":"Williams","year":"2010","journal-title":"Pediatrics"},{"issue":"6","key":"B41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/INF.0b013e318284129a","article-title":"Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants","volume":"32","author":"Sirois","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"B42","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/INF.0000000000000410","article-title":"Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age","volume":"33","author":"Nozyce","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"B43","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1097\/INF.0b013e31829b80ee","article-title":"Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants","volume":"32","author":"Rice","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"B44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/DBP.0b013e318241ed23","article-title":"Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected","volume":"33","author":"Rice","year":"2012","journal-title":"J Dev Behav Pediatr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T10:38:56Z","timestamp":1498300736000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2016.00199\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00199","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}